Hypertension and Type 2 Diabetes Are Associated With Decreased Inhibition of Dipeptidyl Peptidase-4 by Sitagliptin

CONTEXT: Patients with diabetes often have comorbidities such as hypertension. It is not known how individual characteristics influence response to dipeptidyl peptidase-4 (DPP4) inhibitors. OBJECTIVE: We tested the hypothesis that individual characteristics, sitagliptin dose, and genetic variability...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Endocr Soc
Hlavní autoři: Wilson, Jessica R., Shuey, Megan M., Brown, Nancy J., Devin, Jessica K.
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2017
Témata:
Clinical Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5686657/
https://ncbi.nlm.nih.gov/pubmed/29264572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2017-00312
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky